TTD Drug ID: DNC001103

Drug Information
Name	PD180970
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
PubChem Compound ID	CID 5311104.
PubChem Substance ID	SID 7979304.
Target	BCR/ABL protein			Inhibitor	[1]
Ref 1	Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571). Cancer Res. 2002 Dec 15;62(24):7149-53. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.